Search research articles
Contact Us
Filters
Showing results (121-130 of 146) with videos related to
Page
of 15
Sort By:
Journal of the National Cancer Institute
|
November 21, 2002
Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer
Hsueh-Wei Chang, Shing M Lee, Steven N Goodman, et al.
IRB
|
June 26, 2009
An intervention to improve cancer patients' understanding of early-phase clinical trials
Nancy E Kass, Jeremy Sugarman, Amy M Medley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 27, 2009
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning
Yvette L Kasamon, Richard L Wahl, Harvey A Ziessman, et al.
Journal of Clinical and Translational Science
|
December 15, 2025
Key takeaways from Stanford's symposium on AI for Data Science
Manisha Desai, John Auerbach, Laurence Baker, et al.
Lancet (London, England)
|
January 29, 2002
Counting alleles to predict recurrence of early-stage colorectal cancers
Wei Zhou, Steven N Goodman, Gennaro Galizia, et al.
Blood
|
February 4, 2010
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
Leo Luznik, Javier Bolaños-Meade, Marianna Zahurak, et al.
Nature Biotechnology
|
August 18, 2009
Sensitive digital quantification of DNA methylation in clinical samples
Meng Li, Wei-Dong Chen, Nickolas Papadopoulos, et al.
F1000Research
|
November 3, 2020
The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days
Perrine Janiaud, Cathrine Axfors, Janneke Van't Hooft, et al.
Ewha Medical Journal
|
July 31, 2025
CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation
Sally Hopewell, An-Wen Chan, Gary S Collins, et al.
JAMA
|
April 14, 2025
CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials
Sally Hopewell, An-Wen Chan, Gary S Collins, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 146) with videos related to
Sort By:
Page
of 15
Journal of the National Cancer Institute
|
November 21, 2002
Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer
Hsueh-Wei Chang, Shing M Lee, Steven N Goodman, et al.
IRB
|
June 26, 2009
An intervention to improve cancer patients' understanding of early-phase clinical trials
Nancy E Kass, Jeremy Sugarman, Amy M Medley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 27, 2009
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning
Yvette L Kasamon, Richard L Wahl, Harvey A Ziessman, et al.
Journal of Clinical and Translational Science
|
December 15, 2025
Key takeaways from Stanford's symposium on AI for Data Science
Manisha Desai, John Auerbach, Laurence Baker, et al.
Lancet (London, England)
|
January 29, 2002
Counting alleles to predict recurrence of early-stage colorectal cancers
Wei Zhou, Steven N Goodman, Gennaro Galizia, et al.
Blood
|
February 4, 2010
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
Leo Luznik, Javier Bolaños-Meade, Marianna Zahurak, et al.
Nature Biotechnology
|
August 18, 2009
Sensitive digital quantification of DNA methylation in clinical samples
Meng Li, Wei-Dong Chen, Nickolas Papadopoulos, et al.
F1000Research
|
November 3, 2020
The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days
Perrine Janiaud, Cathrine Axfors, Janneke Van't Hooft, et al.
Ewha Medical Journal
|
July 31, 2025
CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation
Sally Hopewell, An-Wen Chan, Gary S Collins, et al.
JAMA
|
April 14, 2025
CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials
Sally Hopewell, An-Wen Chan, Gary S Collins, et al.
Page
of 15